Incorporation of mRNA in Lamellar Lipid Matrices for Parenteral Administration. 2018

Antje Ziller, and Sara S Nogueira, and Eva Hühn, and Sergio S Funari, and Gerald Brezesinski, and Hermann Hartmann, and Ugur Sahin, and Heinrich Haas, and Peter Langguth
Department of Pharmaceutics and Biopharmaceutics, Johannes Gutenberg University Mainz , 55099 Mainz, Germany.

Insertion of high molecular weight messenger RNA (mRNA) into lyotropic lipid phases as model systems for controlled release formulations for the mRNA was investigated. Low fractions of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) were used as an anchor to load the mRNA into a lamellar lipid matrix. Dispersions of zwitterionic lipid in the aqueous phase in the presence of increasing fractions of mRNA and cationic lipid were prepared, and the molecular organization was investigated as a function of mRNA and cationic lipid fraction. Insertion of both cationic lipid and mRNA was clearly proven from the physicochemical characteristics. The d-spacing of the lipid bilayers, as determined by small-angle X-ray scattering (SAXS) measurements, responded sensitively to the amount of inserted DOTAP and mRNA. A concise model of the insertion of the mRNA in the lipid matrices was derived, indicating that the mRNA was accommodated in the aqueous slab between lipid bilayers. Depending on the DOTAP and mRNA fraction, a different excess of water was present in this slab. Results from further physicochemical characterization, including determination of free and bound mRNA, zeta potential, and calorimetry data, were in line with this assumption. The structure of these concentrated lipid/mRNA preparations was maintained upon dilution. The functionality of the inserted mRNA was proven by cell culture experiments using C2C12 murine myoblast cells with the luciferase-encoding mRNA. The described lipid phases as carriers for the mRNA may be applicable for different routes of local administration, where control of the release kinetics and the form of the released mRNA (bound or free) is required.

UI MeSH Term Description Entries
D008051 Lipid Bilayers Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes. Bilayers, Lipid,Bilayer, Lipid,Lipid Bilayer
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008156 Luciferases Enzymes that oxidize certain LUMINESCENT AGENTS to emit light (PHYSICAL LUMINESCENCE). The luciferases from different organisms have evolved differently so have different structures and substrates. Luciferase
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D002412 Cations Positively charged atoms, radicals or groups of atoms which travel to the cathode or negative pole during electrolysis. Cation
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Antje Ziller, and Sara S Nogueira, and Eva Hühn, and Sergio S Funari, and Gerald Brezesinski, and Hermann Hartmann, and Ugur Sahin, and Heinrich Haas, and Peter Langguth
January 1983, Beitrage zu Infusionstherapie und klinische Ernahrung,
Antje Ziller, and Sara S Nogueira, and Eva Hühn, and Sergio S Funari, and Gerald Brezesinski, and Hermann Hartmann, and Ugur Sahin, and Heinrich Haas, and Peter Langguth
March 1980, Deutsche medizinische Wochenschrift (1946),
Antje Ziller, and Sara S Nogueira, and Eva Hühn, and Sergio S Funari, and Gerald Brezesinski, and Hermann Hartmann, and Ugur Sahin, and Heinrich Haas, and Peter Langguth
January 1980, Deutsche medizinische Wochenschrift (1946),
Antje Ziller, and Sara S Nogueira, and Eva Hühn, and Sergio S Funari, and Gerald Brezesinski, and Hermann Hartmann, and Ugur Sahin, and Heinrich Haas, and Peter Langguth
June 1980, Deutsche medizinische Wochenschrift (1946),
Antje Ziller, and Sara S Nogueira, and Eva Hühn, and Sergio S Funari, and Gerald Brezesinski, and Hermann Hartmann, and Ugur Sahin, and Heinrich Haas, and Peter Langguth
January 1996, Nutricion hospitalaria,
Antje Ziller, and Sara S Nogueira, and Eva Hühn, and Sergio S Funari, and Gerald Brezesinski, and Hermann Hartmann, and Ugur Sahin, and Heinrich Haas, and Peter Langguth
January 1996, Nutricion hospitalaria,
Antje Ziller, and Sara S Nogueira, and Eva Hühn, and Sergio S Funari, and Gerald Brezesinski, and Hermann Hartmann, and Ugur Sahin, and Heinrich Haas, and Peter Langguth
January 1986, Beitrage zu Infusionstherapie und klinische Ernahrung,
Antje Ziller, and Sara S Nogueira, and Eva Hühn, and Sergio S Funari, and Gerald Brezesinski, and Hermann Hartmann, and Ugur Sahin, and Heinrich Haas, and Peter Langguth
August 1983, Infusionstherapie und klinische Ernahrung,
Antje Ziller, and Sara S Nogueira, and Eva Hühn, and Sergio S Funari, and Gerald Brezesinski, and Hermann Hartmann, and Ugur Sahin, and Heinrich Haas, and Peter Langguth
April 1965, Schweizerische medizinische Wochenschrift,
Antje Ziller, and Sara S Nogueira, and Eva Hühn, and Sergio S Funari, and Gerald Brezesinski, and Hermann Hartmann, and Ugur Sahin, and Heinrich Haas, and Peter Langguth
January 2003, Journal of controlled release : official journal of the Controlled Release Society,
Copied contents to your clipboard!